Business
PTX Opens First Clinical site for PTX-100 Phase 2a Study
PTX Opens First Clinical site for PTX-100 Phase 2a Study
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]